SecBot SecBot
SECBOTREPLAY Home › Report › PROK

PROK · $200M ATM equity facility

PROKIDNEY CORP. · 424B5 filed Nov 12, 2026 at 08:22 ET

At the news

BEARISHIMPACT 6/10

424B5 filed Nov 12, 2026 at 08:22 ET

ProKidney Corp. filed a 424B5 prospectus supplement establishing a $200 million at-the-market (ATM) equity facility with Jefferies LLC as sales agent. The company has no approved products, no revenue, and reported $141.9 million in cash as of Q3 2026, with cash runway into mid-2027. The ATM program represents potential dilution of up to 86% of current shares outstanding at the reference price of $1.13 per share, following a $650 million universal shelf filed 14 days earlier.

  • ATM facility for up to $200 million of Class A common stock through Jefferies LLC
  • Reference price of $1.13 per share (last reported sale on Nov 11, 2026)
  • Jefferies receives commission of up to 3.0% of gross proceeds
  • At the $1.13 reference price, maximum of 176,991,150 shares could be sold, representing 86% dilution from 205,716,189 shares outstanding as of June 30, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access